ELK4 exerts opposite roles in cytokine/chemokine production and degranulation in activated mast cells.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 22 02 2023
accepted: 14 06 2023
medline: 3 8 2023
pubmed: 2 8 2023
entrez: 2 8 2023
Statut: epublish

Résumé

The proliferative potential of mast cells after activation for 3-4h was found to be decreased, which suggests that mast cell degranulation and cell proliferation are differentially regulated. ELK4, a member of the ternary complex factor (TCF) subfamily of Ets transcription factors, is one of the downstream effectors of MAPK signaling that is critical for cell proliferation. And Elk4 has been identified to be vital for macrophage activation in response to zymosan and the transcriptional response to 12-O-tetrade canoyl phorbol-13-acetate (TPA) stimulation in fibroblast. However, the effect of ELK4 on the mast cell transcriptional response to FcϵRI and GPCR mediated activation and its potential functional significance in mast cells remain unclear. Here, we showed that ELK4 expression is downregulated in activated mast cells.

Identifiants

pubmed: 37529050
doi: 10.3389/fimmu.2023.1171380
pmc: PMC10389778
doi:

Substances chimiques

Cytokines 0
Chemokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1171380

Informations de copyright

Copyright © 2023 Huang, Zhu, Li, Ge, Li, Wang, Peng, Lin, Li, Liu and Li.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Immunol. 2013 May 1;190(9):4500-7
pubmed: 23536637
Nature. 2012 Jul 5;487(7405):114-8
pubmed: 22722849
Curr Opin Immunol. 2021 Oct;72:27-33
pubmed: 33765561
Gene. 2004 Jan 7;324:1-14
pubmed: 14693367
Immunity. 2019 May 21;50(5):1163-1171.e5
pubmed: 31027996
Cell Res. 2002 Mar;12(1):9-18
pubmed: 11942415
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S161-81
pubmed: 20176258
J Biol Chem. 1996 Jul 5;271(27):16268-72
pubmed: 8663278
Am J Respir Crit Care Med. 1995 May;151(5):1354-8
pubmed: 7735584
Blood. 2006 Apr 1;107(7):2814-20
pubmed: 16317093
BMC Genomics. 2014 Apr 23;15:301
pubmed: 24758171
J Histochem Cytochem. 1985 Jan;33(1):27-32
pubmed: 2578142
PLoS Comput Biol. 2013 Apr;9(4):e1002995
pubmed: 23633939
Bone Res. 2018 Mar 28;6:8
pubmed: 29619268
Methods Mol Biol. 2020;2163:247-262
pubmed: 32766982
Neuropathol Appl Neurobiol. 2005 Feb;31(1):70-9
pubmed: 15634233
Annu Rev Biochem. 2011;80:437-71
pubmed: 21548782
Oncogene. 2020 Jun;39(24):4666-4680
pubmed: 32398865
Semin Immunopathol. 2012 Sep;34(5):643-53
pubmed: 22926692
Oncogene. 2016 Mar 3;35(9):1170-9
pubmed: 26028036
J Exp Med. 2017 Sep 4;214(9):2491-2506
pubmed: 28811324
Pulm Pharmacol Ther. 2010 Apr;23(2):121-8
pubmed: 19853667
J Comp Neurol. 2004 Mar 8;470(3):266-81
pubmed: 14755516
J Immunol. 1958 Oct;81(4):355-7
pubmed: 13588003
Cell Immunol. 1993 May;148(2):435-43
pubmed: 8495499
Trends Cell Biol. 2019 Nov;29(11):912-928
pubmed: 31522960
J Immunol. 2007 May 15;178(10):6465-75
pubmed: 17475876
J Allergy Clin Immunol. 2018 Oct;142(4):1173-1184
pubmed: 29277702
Science. 2014 Feb 28;343(6174):1021-5
pubmed: 24505132
Mol Cell Biol. 2005 Dec;25(24):10853-62
pubmed: 16314510
J Biol Chem. 2004 Dec 10;279(50):52543-51
pubmed: 15465815
Genes Dev. 2014 May 1;28(9):943-58
pubmed: 24732378
Front Cell Neurosci. 2019 Jun 18;13:262
pubmed: 31275114
Cell Calcium. 2017 Nov;67:31-39
pubmed: 29029788
EMBO J. 2014 Jun 2;33(11):1212-26
pubmed: 24760698
Immunity. 2019 Nov 19;51(5):949-965.e6
pubmed: 31653482
J Allergy Clin Immunol. 2022 Jan;149(1):156-167.e7
pubmed: 34051221
Front Immunol. 2018 Jul 19;9:1670
pubmed: 30073001
Blood. 1991 Nov 1;78(9):2354-64
pubmed: 1932749
Mol Cell. 2016 Dec 15;64(6):1048-1061
pubmed: 27867007
J Immunol. 1997 Dec 15;159(12):5881-8
pubmed: 9550384
PLoS One. 2014 Jan 22;9(1):e85980
pubmed: 24465823
J Clin Invest. 2016 Oct 3;126(10):3981-3998
pubmed: 27643442
Biochem Pharmacol. 2018 Feb;148:147-154
pubmed: 29274317
Fundam Clin Pharmacol. 2006 Feb;20(1):21-39
pubmed: 16448392
Proc Jpn Acad Ser B Phys Biol Sci. 2010;86(8):848-66
pubmed: 20948178
J Immunol. 2004 Aug 15;173(4):2571-7
pubmed: 15294973
Cell Rep. 2016 May 17;15(7):1566-1579
pubmed: 27160912
Biochim Biophys Acta. 2012 Jan;1822(1):42-8
pubmed: 21236338
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1490-E1499
pubmed: 28167789
J Exp Med. 2006 Feb 20;203(2):337-47
pubmed: 16432253
Traffic. 2012 Jul;13(7):898-907
pubmed: 22420621
J Biol Chem. 1995 Dec 22;270(51):30813-7
pubmed: 8530524
Inflamm Res. 2020 Mar;69(3):289-298
pubmed: 31993675
J Asthma. 2010 May;47(4):374-80
pubmed: 20528589
J Biol Chem. 1996 Oct 25;271(43):26962-70
pubmed: 8900182
Immunity. 2013 Jul 25;39(1):97-110
pubmed: 23871207
Pediatr Clin North Am. 2011 Apr;58(2):363-76, ix-x
pubmed: 21453807
J Cell Biol. 2005 Jul 4;170(1):115-26
pubmed: 15998803
Blood. 2004 Sep 15;104(6):1656-61
pubmed: 15172970
Nat Chem Biol. 2017 May;13(5):529-536
pubmed: 28288109

Auteurs

Yuji Huang (Y)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Zhehui Zhu (Z)

Department of Colorectal Surgery, Shanghai Engineering Research Center of Colorectal Cancer Minimally Invasive Technology, Zhongshan Hospital, Fudan University, Shanghai, China.

Weize Li (W)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Yiqin Ge (Y)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Yanning Li (Y)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Juan Wang (J)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Xia Peng (X)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Lihui Lin (L)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Jia Li (J)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Chen-Ying Liu (CY)

Department of Colorectal and Anal Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Li Li (L)

Department of Laboratory Medicine, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Articles similaires

Animals Dogs Dog Diseases Autophagy Immunohistochemistry
Humans Endoribonucleases RNA, Messenger RNA Caps Gene Expression Regulation

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Natural Killer T-Cells Mice Adipose Tissue Lipid Metabolism

Classifications MeSH